Bioactive Anti-Inflammatory Coating for Chronic Neural Electrodes.
Bioactive anti-inflammatory coating for chronic neural electrodes.
Filed under: Depression Treatment
J Biomed Mater Res A. 2012 Apr 4;
Taub AH, Hogri R, Magal A, Mintz M, Shacham-Diamand Y
Chronic electrodes are widely used for brain degenerative and psychiatric daises such as Parkinson’s diseases, major depression, and obsessive-compulsive disorder, and for neuronal prosthesis. Brain immune reaction to electrodes in the form of glial scar encapsulates the electrode and reduces the efficacy of deep brain stimulation and neuronal prosthesis. State-of-the-art strategies for improving brain-electrode interface use passive protein coating to “camouflage” the electrode from the immune system. In this study, we actively reduced the brain immune reaction to the chronic electrodes using immune suppressing protein, that is, interleukin (IL)-1 receptor antagonist. IL-1 receptor antagonist-coated electrodes and noncoated electrodes were chronically implanted in rats. An additional group of rats was chronically implanted with IL-1 receptor antagonist- and laminin-coated electrodes (as passive protein). Examination of glial scaring 1ne and 4 weeks after implantation indicated a significant reduction in the amount of glial scar in the vicinity of the IL-1 receptor antagonist-coated electrode in comparison to both noncoated electrode and laminin-coated electrodes. The results strongly suggest that active immune suppressing protein reduces the level of immune reaction to chronic electrodes already after 1 week after implantation and generates less immune reaction then passive protein coating. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2012.
HubMed – depression
Sex Differences in Molecular and Cellular Substrates of Stress.
Filed under: Depression Treatment
Cell Mol Neurobiol. 2012 Apr 10;
Bangasser DA, Valentino RJ
Women are twice as likely as men to suffer from stress-related psychiatric disorders, like unipolar depression and post-traumatic stress disorder. Although the underlying neural mechanisms are not well characterized, the pivotal role of stress in the onset and severity of these diseases has led to the idea that sex differences in stress responses account for this sex bias. Corticotropin-releasing factor (CRF) orchestrates stress responses by acting both as a neurohormone to initiate the hypothalamic-pituitary-adrenal (HPA) axis and as a neuromodulator in the brain. One target of CRF modulation is the locus coeruleus (LC)-norepinephrine system, which coordinates arousal components of the stress response. Hypersecretion of CRF and dysregulation of targets downstream from CRF, such as the HPA axis and LC-norepinephrine system, are characteristic features of many stress-related psychiatric diseases, suggesting a causal role for CRF and its targets in the development of these disorders. This review will describe sex differences in CRF and the LC-norepinephrine system that can increase stress sensitivity in females, making them vulnerable to stress-related disorders. Evidence for gonadal hormone regulation of hypothalamic CRF is discussed as an effect that can lead to increased HPA axis activity in females. Sex differences in the structure of LC neurons that create the potential for hyperarousal in response to emotional stimuli are described. Finally, sex differences at the molecular level of the CRF(1) receptor that make the LC-norepinephrine system more reactive in females are reviewed. The implications of these sex differences for the treatment of stress-related psychiatric disorders also will be discussed.
HubMed – depression
Roles of Glutamine Synthetase Inhibition in Epilepsy.
Filed under: Depression Treatment
Neurochem Res. 2012 Apr 10;
Eid T, Behar K, Dhaher R, Bumanglag AV, Lee TS
Glutamine synthetase (GS, E.C. 6.3.1.2) is a ubiquitous and highly compartmentalized enzyme that is critically involved in several metabolic pathways in the brain, including the glutamine-glutamate-GABA cycle and detoxification of ammonia. GS is normally localized to the cytoplasm of most astrocytes, with elevated concentrations of the enzyme being present in perivascular endfeet and in processes close to excitatory synapses. Interestingly, an increasing number of studies have indicated that the expression, distribution, or activity of brain GS is altered in several brain disorders, including Alzheimer’s disease, schizophrenia, depression, suicidality, and mesial temporal lobe epilepsy (MTLE). Although the metabolic and functional sequelae of brain GS perturbations are not fully understood, it is likely that a deficiency in brain GS will have a significant biological impact due to the critical metabolic role of the enzyme. Furthermore, it is possible that restoration of GS in astrocytes lacking the enzyme could constitute a novel and highly specific therapy for these disorders. The goals of this review are to summarize key features of mammalian GS under normal conditions, and discuss the consequences of GS deficiency in brain disorders, specifically MTLE.
HubMed – depression
Yoga Shakti – Yoga Exercises – Triyakbhujangasana – Depression Treatment – Health Tips – The person practising this Asana is advised to drink five to ten glasses of hot water before performing it. This Asana is sure to bring down depression levels and also counter Hypertension. The exercise has been prescribed by Yogacharya Shri Avnish Tiwari. Subscribe NOW to get daily updates on many such useful videos and At-Home Tips www.youtube.com
AMORYN works by increasing the levels of all four of the brain’s “feel good” neurotransmitters. By providing an all-natural boost …
Program your child’s subconscious mind to alleviate symptoms related to depression. Increase your overall peace of mind, energy le…
Attacking Stress Anxiety & Depression The Midwest Center Master Kit! 2008 Edition Product Reatails for over 500 Dollars! Get it he…
Related Depression Treatment Information…